The conduct of clinical research in rare diseases is essential.
4th Conference on Clinical Research for Rare Diseases November 3, 2016 Washington Marriott Wardman Park Washington, DC
Tuesday, October 2, 2012 Despite their rarity, many fundamental advances in medicine have come from the study of rare diseases and these have benefited common diseases. In order to assure the future of this research, the training of the next generation of investigators in this field is important.
Who Should Attend: Abstract & Poster Session:
New investigators, trainees, junior faculty, and others interested in rare disease research methodology. Attendees will have the opportunity to present their work through submission of an abstract and inclusion of a poster session; investigators working on rare diseases will provide feedback and advice. In addition, attendees will: • Meet key leaders in rare diseases research. • Engage in formal and informal networking and idea-generation with other trainees and investigators. • Discuss career development and strategic planning for academic success. • Explore research collaborations.
Registration & Travel Awards:
Registration is $100 and includes: meals, refreshment breaks, and meeting materials. Travel awards of $750 are available on a competitive basis.
For full program details, registration material, and travel award application please visit:
The conduct of clinical research in rare diseases is essential.
Nov 3, 2016 - Engage in formal and informal networking and idea-generation ... this research, the training of the next generation of investigators in this field is ...
Nov 3, 2016 - Attendees will have the opportunity to present their work through submission of an abstract and inclusion of a poster session; investigators ...
Apr 17, 2007 - wrong diagnosis. ⢠25% of patients had to travel to a different ... correct diagnosis. Diseases and Countries. Number of respondents by country.
Jun 17, 2015 - market company of developing an orphan drug would increase by 30 percent. ... figure shows an estimate of the number of approved orphan drugs if the ..... received over 1,800 grant applications since its founding.26 Since ...
Jun 17, 2015 - 6. Box1: Examples of orphan drugs developed since the ODTC . ..... the FDA plus half the time the drug is in preclinical trials (maximum extension of 5 years). ..... versus equity financing, R&D expensing, tax credits, industry ...
job searches, she knows from experience exactly what gets an academic applicant a job. And as the creator of the popular and widely respected advice site The ...
